Ciron Drugs
Home About Us Products Manufacturing R & D Global Presence Virtual Tour Career Contact
                 
Formulations
Formulations
 
Lyophillized
Lyophillized
 
Active Pharmacutical Ingradiants
Active Pharmacutical Ingradiants
 
 
     
 
 
 
 
Announcing...
 
Brand new, state-of-the-art sterile manufacturing facility for Injectables & Ophthalmic products for regulated markets in compliance with PMDA-Japan, USFDA, UK- MHRA, EU & ICH regulatory requirements.

Cirons ultra-modern third manufacturing facility is ready to cater the needs of Regulated & PIC/S markets.
 
 

Yes, we can work together for

  • Technology transfer / Site Transfer /
    Contract manufacturing & supply
    opportunities

  • Out-licensing & In-licensing opportunities

  • Contract development / co-development & marketing

  • All possible collaborations for Japan, USA, Europe, Canada, Australia, South Africa & PIC/S markets.
  •  
     
     

    Salient features of Ciron's new facility

     
  • Fully equipped 80,000 Square feet manufacturing facility
  • Highly automated & 21 CFR Part 11 / EU GMP Annex 11 compliant new machineries
  • Facility design compliance with PMDA - Japan USFDA / EU / ICH CGMP guidelines with
    fully equipped QC Laboratory & Stability units.
  • QMS & DMS software for paperless documentation
  • Seamless Mingling of GMP with QBM-A Business Excellence Tool
  •  

    Outstanding manufacturing capacities

     
  • Ampoules
  • 200,000 units per shift
     
  • Vials
  • 100,000 units per shift
     
  • Lyophilized Vials
  • 80,000 units per cycle
     
  • Eye drops
  • 40,000 units per shift.
     
     
     
    SITEMAP | DISCLAIMER Copyrights Reserved CIRON Drugs & Pharmaceuticals Pvt. Ltd. Creadits